Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Integra Lifesciences (IART)

Integra Lifesciences (IART)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,420,321
  • Shares Outstanding, K 84,843
  • Annual Sales, $ 1,518 M
  • Annual Income, $ 50,200 K
  • 60-Month Beta 1.11
  • Price/Sales 2.91
  • Price/Cash Flow 12.67
  • Price/Book 3.27

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 0.07
  • Number of Estimates 7
  • High Estimate 0.24
  • Low Estimate -0.02
  • Prior Year 0.73
  • Growth Rate Est. (year over year) -90.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.85 +15.28%
on 05/15/20
53.28 -0.80%
on 05/08/20
+3.61 (+7.33%)
since 04/28/20
3-Month
34.21 +54.49%
on 03/18/20
54.16 -2.42%
on 03/04/20
+0.75 (+1.44%)
since 02/28/20
52-Week
34.21 +54.49%
on 03/18/20
65.09 -18.80%
on 07/31/19
+5.23 (+10.98%)
since 05/28/19

Most Recent Stories

More News
Integra LifeSciences Announces Key Executive Leadership Changes

Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced changes to its executive leadership team. Michael McBreen, who is currently the corporate vice president and president of the international...

TCMD : 53.47 (+3.20%)
IART : 52.38 (+0.54%)
Integra LifeSciences Announces Positive Clinical Results for Integra(R) Bilayer Wound Matrix (IBWM)

Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, today announced positive clinical and economic data on Integra Bilayer Wound Matrix (IBWM) in complex...

IART : 52.38 (+0.54%)
Integra LifeSciences Announces May 2020 Investor Conference Schedule

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it will participate in two investor conferences in May.

IART : 52.38 (+0.54%)
Integra (IART) Lags Q1 Earnings Estimates, Withdraws Outlook

Integra's (IART) first-quarter 2020 results reflect disappointing segmental performance due to coronavirus-led business disruptions.

BIIB : 301.80 (+0.11%)
IART : 52.38 (+0.54%)
LLY : 150.95 (+3.60%)
APHA : 4.31 (+2.86%)
Integra LifeSciences (IART) Misses Q1 Earnings Estimates

Integra (IART) delivered earnings and revenue surprises of -20.00% and 0.46%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

IART : 52.38 (+0.54%)
Integra LifeSciences Reports First Quarter 2020 Financial Results

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2020.

IART : 52.38 (+0.54%)
Integra LifeSciences Holdings Corporation Announces Virtual-Only Format for Its 2020 Annual Meeting of Stockholders

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that its 2020 Annual Meeting of Stockholders (the "Meeting") location will change...

IART : 52.38 (+0.54%)
Here's Why You Should Retain HealthEquity Stock for Now

Investor confidence remains high in HealthEquity (HQY) stock, thanks to solid prospects.

IART : 52.38 (+0.54%)
DXCM : 363.11 (+0.97%)
RMD : 158.96 (+3.42%)
HQY : 62.14 (-1.72%)
Bio-Rad Launches Serology Test to Detect Coronavirus Antibody

Bio-Rad (BIO) launches a blood-based immunoassay kit to better detect antibodies in response to SARS-CoV-2 infection.

IART : 52.38 (+0.54%)
RMD : 158.96 (+3.42%)
BIO : 477.83 (+1.51%)
EYE : 26.66 (-6.49%)
Why Integra (IART) Could Beat Earnings Estimates Again

Integra (IART) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

IART : 52.38 (+0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade IART with:

Business Summary

Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic surgery, neurosurgery, reconstructive and general surgery. Integra's orthopedic...

See More

Key Turning Points

2nd Resistance Point 54.03
1st Resistance Point 53.07
Last Price 52.38
1st Support Level 51.02
2nd Support Level 49.93

See More

52-Week High 65.09
Fibonacci 61.8% 53.29
Last Price 52.38
Fibonacci 50% 49.65
Fibonacci 38.2% 46.01
52-Week Low 34.21

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar